Gilead Announces Clinical Hold on Studies Evaluating Injectable Lenacapavir for HIV Treatment and Prevention Due to Vial Quality Concerns Pharmaceutical Investing
Gilead and Arcus Biosciences Complete Closing of Option Exercise for Three Clinical-Stage Programs and New Research Collaboration Pharmaceutical Investing
European Commission Expands Indication for Veklury for the Treatment of Adults Not on Supplemental Oxygen and Considered High Risk for COVID-19 Disease Progression Pharmaceutical Investing
FDA APPROVES OTEZLA® FOR THE TREATMENT OF ADULT PATIENTS WITH PLAQUE PSORIASIS, REGARDLESS OF SEVERITY LEVEL Market News
Sirona Biochem Antiviral Compounds to be Tested Against SARS-CoV-2 by Top US Testing Facility Biotech Investing
BELLUS Health Closes US$200 Million Public Offering of Common Shares in Canada and the United States Pharmaceutical Investing
Bristol Myers Squibb to Report Results for Fourth Quarter 2021 on February 4, 2022 Pharmaceutical Investing
Daiichi Sankyo Authorizes the First YESCARTA® CAR T-cell Therapy Treatment Site in Japan Pharmaceutical Investing
